T38.7X2S Poisoning by androgens and anabolic congeners, intentional self-harm, sequela

Name of the Condition

• Poisoning by androgens and anabolic congeners, intentional self-harm, sequela

Summary

This condition represents the residual effects (sequela) of intentional self-harm involving androgens or anabolic congeners. It applies to cases where the initial poisoning event has resolved, but long-term consequences persist. The code distinguishes these sequelae from active poisoning or acute events, focusing on ongoing or chronic manifestations resulting from the prior self-harm incident.

Causes

Sequelae from intentional self-harm with androgens or anabolic agents arise from the residual impact of the initial poisoning. The original event may involve deliberate overdose, misuse, or self-administration of these substances, with lasting effects occurring after the acute phase has subsided. Underlying factors like pre-existing health conditions or the specific agent used can influence the nature of sequelae.

Risk Factors

• History of intentional self-harm or suicidal behavior
• Prior exposure to androgens or anabolic congeners
• Co-occurring mental health conditions
• Chronic effects from the initial poisoning (e.g., organ damage)
• Inadequate follow-up care post-incident

Symptoms

Symptoms reflect persistent or delayed effects of the initial poisoning and may include chronic virilization (e.g., persistent voice changes, hirsutism), ongoing hepatic dysfunction, cardiovascular complications (e.g., hypertension), or psychological sequelae related to the self-harm event. The specific manifestations depend on the agent and severity of the original exposure.

Diagnosis

Diagnosis requires confirmation of prior intentional self-harm with androgens or anabolic congeners and evidence of residual effects. Clinical evaluation assesses ongoing symptoms, reviews the history of the initial event, and may include laboratory tests or imaging to identify persistent organ damage or metabolic abnormalities. Documentation must link current findings to the prior poisoning.

Treatment Options

Management focuses on addressing residual symptoms and preventing recurrence. This may involve monitoring for organ dysfunction, psychological support, or interventions to manage chronic effects (e.g., endocrine therapy for persistent virilization). Treatment plans are individualized based on the specific sequelae and patient needs.

Prognosis and Follow-Up

Prognosis varies depending on the severity of sequelae and the success of management. Regular follow-up is essential to monitor for complications, adjust treatments, and address psychological or social factors. Long-term outcomes may include partial or complete resolution of symptoms, depending on the extent of initial damage and adherence to care plans.

Complications

Potential complications include irreversible organ damage (e.g., hepatic or cardiovascular), persistent endocrine abnormalities, or recurrent self-harm. Psychological sequelae, such as depression or anxiety, may also arise and require ongoing intervention.

Lifestyle & Prevention

Lifestyle modifications may support recovery, such as adhering to prescribed therapies, avoiding substance misuse, and engaging in mental health support. Prevention focuses on addressing underlying risk factors, improving access to mental health care, and ensuring safe storage of medications to reduce future incidents.

When to Seek Professional Help

Seek care if new or worsening symptoms emerge, such as severe pain, changes in organ function, or signs of recurrent self-harm. Prompt evaluation is critical for managing complications or adjusting treatment plans to optimize outcomes.

Tips for Medical Coders

Document the prior intentional self-harm event and confirm the presence of residual effects (sequela) to justify this code. Ensure clinical notes specify the link between current manifestations and the original poisoning. Code T38.7X2S is appropriate only when sequelae are directly attributable to the prior self-harm incident and are not part of an active poisoning episode.